NCT06988111View on ClinicalTrials.gov

Management of Post-operative Respiratory Failure by Using NIV and High Velocity Nasal Insufflation (HVNI)

NANot yet recruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

July 1, 2026

Study Completion Date

December 1, 2026

Conditions
Respiratory Failure Without HypercapniaRespiratory Failure With HypercapniaPostoperative Respiratory Complication
Interventions
DEVICE

BIPAP

The second arm (NIV group) will be managed by BIPAP device for post-operative respiratory failure

DEVICE

Vapotherm

The first arm (HVNC group) will be managed by Vapotherm device for post-operative respiratory failure

Trial Locations (1)

71515

Assuit Univeristy, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT06988111 - Management of Post-operative Respiratory Failure by Using NIV and High Velocity Nasal Insufflation (HVNI) | Biotech Hunter | Biotech Hunter